History of Injection Drug Use, HCV Linked to Persistent Immunological Changes After DAA Therapy
“Curative DAA therapy did not completely normalize immune activation and inflammatory biomarkers in individuals with a history of injection drug use and HCV infection.”
Home-testing kits for hepatitis C made available in England
“Self-testing kits for hepatitis C are being made available from the NHS in England from Saturday. The free, confidential service is designed to reach people who may not access other services or do not feel able to approach their GP.”
Health professionals push to reduce infections killing Missouri babies
“The bill would also require a third trimester test for HIV and hepatitis C and hepatitis B, which can cause liver damage in infants.”
By combining offices, we are working to ensure compassionate, empathetic, and efficient service
“Recent data show that while Arizona’s rate of HIV infection has gone up slightly from the previous year, the rate of death from complications from the disease has decreased. This positive trend is due to multiple prevention methods, but most prominently the use of antiretrovirals (ARVs) improve outcomes at the highest rate. Access to medication is vital to reducing deaths due to this disease. This important prevention and education is done by our Preparedness team members in the newly formed Office of HIV and Hepatitis C Services.”
Memorializing Governor Kathy Hochul to proclaim March 2024, as Bleeding Disorders Awareness Month in the State of New York
“WHEREAS, In the 1980s, treatment finally became available for those suffering with these disorders; unfortunately, the treatments gave rise to the scourge of HIV/AIDS and Hepatitis C from contaminated blood; as a result, over 10,000 people with bleeding disorders died, and those who survived lived profoundly altered lives; and”
The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes
“Sofosbuvir is one of the crucial drugs used in the treatment of chronic hepatitis C virus (HCV) in adults and children with compensated liver disease, including cirrhosis. It may be used alone or with other drugs. Ribavirin is an antiviral medication used to treat HCV infection. It is not effective when used alone and must be used in combination with other medications, such as sofosbuvir.”
Hepatitis C virus detection and management after implementation of universal screening in pregnancy.
“Accurately identifying cases of hepatitis C virus has important medical and public health consequences. In the setting of rising hepatitis C virus prevalence and highly effective treatment with direct-acting antivirals, the Society for Maternal-Fetal Medicine guidelines recently changed to recommend universal screening for hepatitis C virus during pregnancy. However, there is little data on the influence of this policy change on case identification and management.”
Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia.
“Organ transplantation from donors with hepatitis C viremia (HCV) to recipients without HCV (HCV D+/R-) has excellent medical outcomes. Less is known about the psychosocial impact and experiences of HCV D+/R- recipients, particularly outside of clinical trials.”
Beneficial Treatment for Early-Stage Hepatitis C and HIV Co-Infection
“Shortened treatments have shown promise in the early stages of hepatitis C (HCV), with a study on the 4-week glecaprevir/pibrentasvir (G/P) regimen presented at the Conference on Retroviruses and Opportunistic Infections (CROI), highlights a promising strategy for HCV elimination, particularly in HIV co-infected populations.”
Hepatitis C Treatment Can Improve Liver Function in People With Decompensated Cirrhosis
““The Punjab HCV Model demonstrates that recompensation of cirrhosis is achievable,” but these patients should still receive regular liver cancer surveillance, as their risk remains elevated, the researchers concluded. “Patients with cirrhosis should be followed up following virological cure for new decompensations and hepatocellular carcinoma, which should be integrated in public healthcare policy for HCV elimination,” they recommended.”
